Cancer Therapy
Research offers in-depth competitive landscape assessment of targeted oncology market place
Published in Vaccine Weekly, December 20th, 2006
The dogma for treatment of cancer has changed, with the cytotoxic drugs used in chemotherapy regimes set to lose their dominance and be used alongside targeted therapies that are being developed with the aim of more specifically targeting cancer cells.
In this comprehensive report covering targeted therapies in oncology, researchers have analyzed protein kinase inhibitors, antiangiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology.
This extensive 410+ page report compiles...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-12-20)
More Articles from Vaccine Weekly
- Avian Influenza
Sophy beta-glucan shown to enhance efficacy of vaccines against avian flu and other viruses - Influenza Vaccine
Roche to revise Tamiflu label in U.S. to include reports of neuropsychiatric events - DNA Vaccines
New DNA vaccines data have been reported by investigators at National Institute of Toxicological Research, Department of Pharmacology - Avian Influenza
Novartis secures contract to supply additional H5N1 bird flu vaccine - Business Update
Crucell presents update on products and programs at New York analyst meeting - Business Update
GlaxoSmithKline awarded U.S. Department of Health and Human Services contract - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
